Journal of Asthma and Allergy
Volume 14, 2021 - Issue
Open access
383
Views
12
CrossRef citations to date
0
Altmetric
Original Research
Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial
Jonathan Corren1 Departments of Medicine and Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, CA, USACorrespondence[email protected]
View further author information
, View further author information
Sarbjit S Saini2 Department of Internal Medicine, Division of Allergy and Clinical Immunology, Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USAhttps://orcid.org/0000-0001-8522-2742View further author information
, Remi Gagnon3 Clinique Spécialisée en Allergie de la Capitale, Québec, QC, CanadaView further author information
, Mark H Moss4 Departments of Medicine and Pediatrics, Division of Allergy, Pulmonary and Critical Care, University of Wisconsin School of Medicine and Public Health, Madison, WI, USAView further author information
, Gordon Sussman5 Department of Medicine, University of Toronto, Toronto, ON, CanadaView further author information
, Joshua Jacobs6 Allergy and Asthma Clinical Research, Inc, Walnut Creek, CA, USAView further author information
, Elizabeth Laws7 Sanofi, Bridgewater, NJ, USAView further author information
, Elinore S Chung8 Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USAView further author information
, Tatiana Constant8 Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USAhttps://orcid.org/0000-0001-8619-8131View further author information
, Yiping Sun8 Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USAView further author information
, Jennifer Maloney8 Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USAView further author information
, Jennifer D Hamilton8 Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USAView further author information
, Marcella Ruddy8 Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USAView further author information
, Claire Q Wang8 Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USAView further author information
& Meagan P O’Brien8 Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USACorrespondence[email protected]
View further author information
show allView further author information
Pages 1045-1063
|
Published online: 16 Aug 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.